{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:46Z","timestamp":1786998466173,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["IIR #WI171341"],"award-info":[{"award-number":["IIR #WI171341"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ymgme.2016.07.010","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T01:43:58Z","timestamp":1469238238000},"page":"144-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Development of a model system for neuronal dysfunction in Fabry disease"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1453-2502","authenticated-orcid":false,"given":"Christine R.","family":"Kaneski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roscoe O.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Hanover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike H.","family":"Schueler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2016.07.010_bb0005","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.2174\/13816128113199990352","article-title":"Anderson-Fabry disease: a multiorgan sdisease","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/jhg.2011.31","article-title":"Fabry-database. org: database of the clinical phenotypes, genotypes and mutant \u03b1-galactosidase A structures in Fabry disease","volume":"56","author":"Saito","year":"2011","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0015","author":"Schiffmann"},{"key":"10.1016\/j.ymgme.2016.07.010_bb0020","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.32.5.498","article-title":"Fabry disease impaired autonomic function","volume":"32","author":"Cable","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2016.07.010_bb0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00697017","article-title":"Neuropathological and biochemical studies in Fabry's disease","volume":"30","author":"Tabira","year":"1974","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0030","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1212\/WNL.52.6.1249","article-title":"Quantitative analysis of epidermal innervation in Fabry disease","volume":"52","author":"Scott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2016.07.010_bb0035","first-page":"61","article-title":"Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy","volume":"106","author":"Schiffmann","year":"2006","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jmg.20.4.309","article-title":"Involvement of dorsal root ganglia in Fabry's disease","volume":"20","author":"Gadoth","year":"1983","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0045","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2015.01.084","article-title":"The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain","volume":"594","author":"Choi","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.nbd.2003.08.016","article-title":"Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3","volume":"14","author":"Schueler","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0060","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.2174\/13816128113199990387","article-title":"Neurological complications of Anderson-Fabry disease","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108641","article-title":"Pain related channels are differentially expressed in neuronal and non-neuronal cells of glabrous skin of fabry knockout male mice","volume":"9","author":"Lakom\u00e1","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2016.07.010_bb0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0006-8993(89)91253-5","article-title":"Acetylcholine synthesis and secretion by LA-N-2 human neuroblastoma cells","volume":"476","author":"Richardson","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0075","author":"GPP Web Portal"},{"key":"10.1016\/j.ymgme.2016.07.010_bb0080","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1046\/j.1471-4159.1998.70041411.x","article-title":"Collaborative and reciprocal effects of ciliary neurotrophic factor and nerve growth factor on the neuronal phenotype of human neuroblastoma cells","volume":"70","author":"Zinman","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0085","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1194\/jlr.D007294","article-title":"Use of lissamine rhodamine ceramide trihexoside as a functional assay for alpha-galactosidase A in intact cells","volume":"51","author":"Kaneski","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","article-title":"Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease","volume":"112","author":"Mayes","year":"1981","journal-title":"Clin. Chem. Acta."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0095","doi-asserted-by":"crossref","DOI":"10.1007\/8904_2015_507","article-title":"A short synthetic peptide mimetic of apolipoprotein a1 mediates cholesterol and globotriaosylceramide efflux from Fabry fibroblasts","author":"Schueler","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0100","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1046\/j.1471-4159.2003.02292.x","article-title":"Detection of basal and potassium-evoked acetylcholine release from embryonic DRG explants","volume":"88","author":"Bernardini","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0105","series-title":"Epidermal Cells Methods Protoc.","article-title":"Fluorimetric DNA assay of cell number","volume":"251\u2013262","author":"Otto","year":"2005"},{"key":"10.1016\/j.ymgme.2016.07.010_bb0110","first-page":"1364","article-title":"Morphology, growth, chromosomal pattern, and fibrinolytic activity of two new human neuroblastoma cell lines","volume":"37","author":"Seeger","year":"1977","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0006-8993(83)90241-X","article-title":"PGP 9.5 \u2013 a new marker for vertebrate neurons and neuroendocrine cells","volume":"278","author":"Thompson","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/gb-2003-4-9-117","article-title":"Comparing protein abundance and mRNA expression levels on a genomic scale","volume":"4","author":"Greenbaum","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ki.2013.520","article-title":"Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease","volume":"86","author":"Shu","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ki.2008.576","article-title":"Downregulation of \u03b1-galactosidase A upregulates CD77: functional impact for Fabry nephropathy","volume":"75","author":"Thomaidis","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0306-4522(88)90240-0","article-title":"Snyapse-competence of LA-N-2 human neuroblastoma cells in cocultue with rat striated muscle cells","volume":"27","author":"Yeh","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymgme.2016.07.010_bb0140","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jnr.490250405","article-title":"Enzymatic activities during differentiation of the human neuroblastoma cells, LA-N-1 and LA-N-2","volume":"25","author":"Singh","year":"1990","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0145","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1471-4159.1993.tb13632.x","article-title":"Regulation of expression of cholinergic neuronal phenotypic markers in neuroblastoma LA-N-2","volume":"61","author":"Rylett","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0150","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/0024-3205(96)00189-0","article-title":"Differentiation agents enhance cholinergic characteristics of LA-N-2 human neuroblastoma cells","volume":"58","author":"Crosland","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0155","series-title":"Mol. Chem. Neuropathol. Spons. Int. Soc. Neurochem. World Fed. Neurol. Res. Groups Neurochem. Cerebrospinal Fluid","first-page":"77","article-title":"Presence of functional NMDA receptors in a human neuroblastoma cell line","volume":"30","author":"North","year":"1997"},{"key":"10.1016\/j.ymgme.2016.07.010_bb0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","article-title":"Natural history of Fabry renal disease: influence of \u03b1-galactosidase A activity and genetic mutations on clinical course","volume":"81","author":"Branton","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.ymgme.2016.07.010_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003632","article-title":"Functional characterisation of alpha-galactosidase A mutations as a basis for a new classification system in Fabry disease","volume":"9","author":"Lukas","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0170","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jcp.25072","article-title":"Characterization of human dermal fibroblasts in Fabry disease: VRACs EXPRESSION IN FABRY DISEASE","volume":"231","author":"Lakom\u00e1","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1471-4159.2005.03367.x","article-title":"A model for dynamic regulation of choline acetyltransferase by phosphorylation","volume":"95","author":"Dobransky","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0180","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/BJ20121662","article-title":"Regulation of cholinergic activity by the vesicular acetylcholine transporter","volume":"450","author":"Prado","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2004.01.011","article-title":"Fabry disease: reduced activities of respiratory chain enzymes with decreased levels of energy-rich phosphates in fibroblasts","volume":"82","author":"L\u00fccke","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0190","doi-asserted-by":"crossref","first-page":"154907","DOI":"10.1063\/1.4918585","article-title":"Influence of length and conformation of saccharide head groups on the mechanics of glycolipid membranes: unraveled by off-specular neutron scattering","volume":"142","author":"Yamamoto","year":"2015","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0195","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/cvr\/cvq333","article-title":"Globotriaosylceramide leads to KCa3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease","volume":"89","author":"Park","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0200","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0306-4522(97)80196-0","article-title":"Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. II. The peripheral nervous system","volume":"84","author":"Sch\u00e4fer","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymgme.2016.07.010_bb0205","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00441-012-1536-z","article-title":"Peripheral choline acetyltransferase in rat skin demonstrated by immunohistochemistry","volume":"351","author":"Hanada","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ymgme.2016.07.010_bb0210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1227\/NEU.0000000000001255","article-title":"The dorsal root ganglion in the pathogenesis of chronic neuropathic pain","volume":"63","author":"Guha","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ymgme.2016.07.010_bb0215","first-page":"685","article-title":"Mechanisms and controllers of eccrine sweating in humans","volume":"2","author":"Shibasaki","year":"2010","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.ymgme.2016.07.010_bb0220","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1651-2227.2002.tb03110.x","article-title":"Pathophysiology and assessment of neuropathic pain in Fabry disease","volume":"91","author":"Schiffmann","year":"2002","journal-title":"Acta Paediatr."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719216301512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719216301512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T04:28:35Z","timestamp":1536553715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719216301512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":44,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1096719216301512"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.07.010","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a model system for neuronal dysfunction in Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}